-

Agilent Launches New GC Systems with GC Assist to Improve Laboratory Efficiency and Data Quality

New 8890B and 8860B gas chromatographs integrate intelligent monitoring and remote diagnostics

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of the new 8890B GC and 8860B GC with GC Assist. GC Assist is the new, advanced instrument intelligence that provides system monitoring, built-in troubleshooting, and remote connectivity to analytical instrumentation within the laboratory’s secure network. These systems enable higher performance and productivity across gas chromatography analyses.

The new systems are designed to help laboratories reduce unplanned downtime, improve data quality, and operate more efficiently by combining updated GC hardware with integrated system monitoring, diagnostics, step-by-step troubleshooting, and maintenance procedures through GC Assist.

“These are our most advanced GC systems to date,” said Warren Potts, vice president and general manager of the Gas Phase Division at Agilent. “Laboratories are under pressure to deliver high-quality data while managing limited resources. By embedding intelligence into the instrument platform, GC Assist helps scientists identify issues earlier, maintain performance, and stay focused on their analytical work.”

The 8890B and 8860B extend GC system capabilities with enhancements designed to support higher throughput, flexibility, and ease of use. An oven light improves visibility during maintenance, while onboard maintenance videos help new users complete routine procedures. The 8860B GC increases throughput with dual simultaneous injections, while the 8890B adds flexibility with an additional detector position, supporting up to four detectors in valve configurations. The 8890B also offers up to a 30% faster oven cooling rate compared to previous models, reducing injection-to-injection cycle times and enabling laboratories to increase daily sample throughput without changing established method parameters.

GC Assist is the integrated intelligence for these systems, helping labs deliver consistent, reproducible results every day. It enables scientists to monitor instrument status, track data quality, and perform troubleshooting locally or remotely across secure laboratory networks. The system flags results that fall outside predefined quality control limits, notifies users when maintenance is required, and provides step-by-step guidance and procedures to support consistent operation and maintenance across experience levels.

GC Assist enables continuous monitoring of system performance, gas and power usage, and indicators of carrier gas leaks. By identifying issues early, GC Assist helps laboratories reduce reruns caused by system issues or unmet quality control criteria, saving time and resources while supporting operational efficiency and laboratory sustainability goals.

The new systems are being introduced globally and will be supported through Agilent’s worldwide sales, service, and application teams.

About Agilent Technologies

Agilent Technologies, Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.95 billion in fiscal year 2025 and employs approximately 18,000 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn and Facebook.

Contacts

Media Contact
Kate Coyle
Agilent Technologies Inc.
+1 302-633-7490
kate.coyle@agilent.com

Agilent Technologies Inc.

NYSE:A
Details
Headquarters: Santa Clara, California, USA
CEO: Padraig McDonnell
Employees: 18000
Organization: PUB

Release Versions

Contacts

Media Contact
Kate Coyle
Agilent Technologies Inc.
+1 302-633-7490
kate.coyle@agilent.com

Social Media Profiles
More News From Agilent Technologies Inc.

Agilent Expands Altura Portfolio with Inert Size Exclusion and PLRP-S Columns for Biotherapeutic Analysis

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the latest expansion of its Altura HPLC column portfolio with the introduction of Altura size exclusion chromatography (SEC) and Altura PLRP-S columns, designed to support critical analytical workflows in biopharmaceutical development and production.The new SEC and PLRP-S columns support critical analytical workflows across a range of biotherapeutic modalities, including peptides, proteins, oligonucleotides...

Agilent Launches AI-Driven Analysis Module for Agilent xCELLigence RTCA eSight

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of Agilent xCELLigence RTCA eSight AI, a new AI-powered software module that simplifies label-free imaging analysis by reducing manual cell segmentation steps and parameter tuning and supporting more consistent results. The software upgrade enhances the unique dual-readout capabilities of the Agilent xCELLigence RTCA eSight instrument with AI-driven cell imaging analysis, enabling researchers to...

Agilent Completes Acquisition of Biocare Medical

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the successful completion of its previously announced acquisition of Biocare Medical, a global leader in clinical pathology, from an investor group led by Excellere Partners and GHO Capital Partners LLP. Following the close of the transaction, Biocare is now part of Agilent’s Life Sciences and Diagnostics Markets Group.“We are pleased to complete our acquisition of Biocare, which represents a natural and st...
Back to Newsroom